From Corestem to Yuhan: Cellbion Eyes Fast-Track Path for Lu-177-DGUL
created on 08/27/2025 8:27:18 AM
Unauthorized reproduction or distribution is illegal and subject to criminal penalties.
Pharm Edaily enforces a zero-tolerance policy and will take strict action.
Pharm Edaily enforces a zero-tolerance policy and will take strict action.
Premium Content
이 기사는 유료 구독자를 위한 프리미엄 콘텐츠입니다.
유료 구독(플래티넘)을 통해 더 많은 콘텐츠를 만나보세요.
This article is premium content for paid subscribers.
Subscribe to paid subscription (Platinum) for full access.
함께보면 좋은 뉴스
![Inventage Lab, Quratis surge on Boehringer deal; Alteogen falls[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/08/PS25082800186b.jpg)
![베링거發 훈풍에 인벤티지랩·큐라티스 上…알테오젠 ‘약세’[바이오 맥짚기]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/08/PS25082800183b.jpg)
